Abstract：Objective: To observe the application value of SRM-IV system in the induction test of benign paroxysmal positional vertigo of superior semicircular canal (AC-BPPV). Methods: 110 patients with ac-bppv admitted to Baise people's Hospital from February 2018 to February 2021 were prospectively selected and randomly divided into experimental group (n = 55) and control group (n = 55) by simple random sampling method. The patients in the experimental group were treated with srm-iv diagnosis and treatment system, while the patients in the control group were treated with conventional manipulative reduction. Both groups were treated for 1 week. The total effective rate, cure time, subjective and objective symptoms, improvement of quality of life, occurrence of complications and recurrence rate of the two groups were compared after one week of treatment. Results: The total effective rate of the experimental group (96.36%) was significantly higher than that of the control group (81.82%), the difference was statistically significant( χ2=11.652,P<0.05). The cure time of the experimental group [(6. 13 1 ± 66) D] was significantly shorter than that in the control group [(6. 99 0 ± 74) D], the difference was statistically significant (t = 5. 443, P< 0. 05). The difference of subjective and objective symptom related scores (UCLA-DQ, MSQ) before and after treatment in the experimental group [(2.46 0.05)] ± 14)] (63. 10 0 ± 59), which was significantly higher than that of the control group [(1. 58 6 ± 28) (49. 22 0 ± 41)]. The difference of quality of life (DHI) score before and after treatment [(36.12 1 ± 33), which was significantly higher than that of the control group [(22. 50 2 ± 10)]. The incidence of complications in the experimental group (3.64%) was significantly lower than that in the control group (18.18%), the difference was statistically significant (P<0.05). There was no significant difference in the recurrence rate between the experimental group (3.64%) and the control group (5.45%) (P>0.05). Conclusion: The SRM-IV diagnosis and treatment system plays an active role in the diagnosis and treatment of benign paroxysmal positional vertigo in the upper semicircular canal. The treatment effect is significant with few complications, safe and reliable, and at the same time, it significantly improves the subjective and objective symptoms and quality of life of patients. It is suitable for clinical practice and application.
杨秋云, 蒙楠, 韦福依. SRM-IV诊疗系统在上半规管良性阵发性位置性眩晕诊治中的应用价值[J]. 河北医学, 2021, 27(7): 1178-1181.
YANG Qiuyun, MENG Nan, WEI Fuyi. Application Value of Srm-iv System in Diagnosis and Treatment of Superior Semicircular Canal Benign Paroxysmal Positional Vertigo. HeBei Med, 2021, 27(7): 1178-1181.
2021, Vol. 27 
冀公网安备13080202000677号